In their recent study, Otto and colleagues suggested that the adverse effects of hyperglycaemia on immune function may be mediated by hyperosmotic stress [1]. In granulocytes both oxidative burst and phagocytosis were suppressed by hyperosmolar stress with mannitol, but no significant effect was observed on cytokine release from peripheral blood mononuclear cells [1]. The concentration of glucose (and mannitol) used in these experiments (500 mg/dl or 27.8 mmol/l), however, is rarely encountered in critically ill patients – and then only transiently. One may question how relevant this mechanism is, when it appears that modest levels of hyperglycaemia (11.1 mmol/l) have deleterious effects in this population [2].
Modest hyperglycaemia has been demonstrated to directly perturbate immune function by more than one mechanism. Macropinocytosis by macrophages involves nonspecific sampling of pathogens in extracellular fluid, which are then directed towards antigen processing with subsequent presentation of microbial peptides to T cells, linking innate and adaptive immunity. Macropinocytosis is reduced in a dose-dependent manner by glucose but not by mannitol. Increasing glucose from 5.5 to 11.1 mmol/l inhibited macropinocytosis by 55% [3]. Surfactant proteins A and D and mannose-binding lectin are important host defence molecules (collectins), which bind pathogens, augment opsonisation, phagocytosis and killing by macrophages and neutrophils, and activate complement. Deficiency in mannose-binding lectin is associated with septic shock and death in critically ill patients [4]. Glucose competitively inhibits pathogen binding by collectins [5] and represents an eloquent mechanism of how modest hyperglycaemia may increase susceptibility to infection.
We would suggest that the benefits of strict glycaemic control on immune function in critical care might be explained by the direct effects of glucose rather than by reductions in hyperosmolar stress.
Competing interests
The authors declare that they have no competing interests.
See related research by Otto et al., http://ccforum.com/content/12/4/R107 and related commentary by Wade, http://ccforum.com/content/12/5/182
Contributor Information
Matt P Wise, Email: mattwise@doctors.org.uk.
Anton G Saayman, Email: Anton.Saayman@CardiffandVale.wales.nhs.uk.
Paul J Frost, Email: Paul.Frost@CardiffandVale.wales.nhs.uk.
References
- Otto NM, Schindler R, Lun A, Boenisch O, Frei U, Oppert O. Hyperosmotic stress enhances cytokine production and decreases phagocytosis in vitro. Crit Care. 2008;12:R107. doi: 10.1186/cc6989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berghe G Van den, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–1367. doi: 10.1056/NEJMoa011300. [DOI] [PubMed] [Google Scholar]
- Guest CB, Chakour KS, Freund GG. Macropinocytosis is decreased in diabetic mouse macrophages and is regulated by AMPK. BMC Immunol. 2008;9:42. doi: 10.1186/1471-2172-9-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garred PJ, Strom J, Quist L, Taaning E, Madsen HO. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis. 2003;188:1394–1403. doi: 10.1086/379044. [DOI] [PubMed] [Google Scholar]
- Reading PC, Allison J, Crouch EC, Anders EM. Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose? J Virol. 1998;72:6884–6887. doi: 10.1128/jvi.72.8.6884-6887.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]